Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-054445

Epizyme, Inc. · EPZM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David M Mott
Director
Period of report
Oct 5, 2018
Accepted (ET)
Oct 5, 2018 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Oct 5, 2018P416,667$9.00A6,471,018ISee Note 2
Common StockF3holding———406,500ISee Note 3
Common StockF4holding———651ISee Note 4
Common Stockholding———12,088D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses